Desonate: Phase III data

Pooled data from 2 double-blind Phase III trials in 582 patients showed that twice-daily Desonate for 4 weeks met all primary (p<0.001) and secondary (p<=0.006) endpoints vs. hydrogel vehicle treatmen...